ϩ -ATPase (V-ATPase) and acidify the lumen of the epididymis, a process that is essential for male fertility. The renin-angiotensin-aldosterone system (RAAS) regulates fluid and electrolyte balance in the epididymis, and a previous study showed binding of aldosterone exclusively to epididymal clear cells (Hinton BT, Keefer DA. Steroid Biochem 23: 231-233, 1985). We examined here the role of aldosterone in the regulation of V-ATPase in the epididymis. RT-PCR showed expression of the mineralocorticoid receptor [MR; nuclear receptor subfamily 3, group C member 2 (NR3C2)] and 11-␤-dehydrogenase isozyme 2 (HSD11␤2) mRNAs specifically in clear cells, isolated by fluorescence-activated cell sorting from B1-enhanced green fluorescent protein (EGFP) mice. Tail vein injection of adult rats with aldosterone, 1,2-dioctanoyl-snglycerol (DOG), or 8-(4-chlorophenylthio)-cAMP (cpt-cAMP) induced V-ATPase apical membrane accumulation and extension of V-ATPaselabeled microvilli in clear cells in the caput epididymis but not in the cauda. V-ATPase activity was measured in EGFP-expressing clear cells using the intracellular pH (pH i)-sensing dye seminaphthorhodafluor-5F-5-(and 6)-carboxylic acid, acetoxymethyl ester acetate (SNARF-5F). Aldosterone induced a rapid increase in the rate of Na ϩ -and bicarbonate-independent pH i recovery following an NH4Cl-induced acid load in clear cells isolated from the caput but not the cauda. This effect was abolished by concanamycin A, spironolactone, and chelerythrine but not myristoylated-protein kinase inhibitor (mPKI) or mifepristone. Thus aldosterone increases V-ATPasedependent proton secretion in clear cells in the caput epididymis via MR/NR3C2 and PKC activation. This study, therefore, identifies aldosterone as an active member of the RAAS for the regulation of luminal acidification in the proximal epididymis. aldosterone; nongenomic; epididymis; clear cell; V-ATPase pump THE EPIDIDYMIS IS AN IMPORTANT male reproductive organ involved in the maturation and storage of spermatozoa. The pseudostratified epithelium of the epididymis is composed of numerous cell types, including principal, basal, and clear cells that function in concert to tightly regulate the luminal environment in which sperm transit (51). One major function of clear cells in the epididymis is to acidify the luminal fluid via the vacuolar proton-pumping H ϩ -ATPase (V-ATPase), which is located on the apical membrane (6, 7, 13, 14) . Under resting conditions, a large fraction of V-ATPase resides in a subapical pool of vesicles, and upon activation the V-ATPase is trafficked to the apical membrane. This is accompanied by an increase in apical membrane surface area resulting in the formation and elongation of apical microvillar projections. Thus microvilli elongation directly correlates with V-ATPase activity and has been used as a measure of clear cell activation (6, 7, 19, 39, 49) . The importance of clear cells to male fertility has been demonstrated, as impairment of V-ATPase activity by genetic manipulation or by environmental factors causes male infertility (11, 27, 61 ). An acidic pH is important for maintaining spermatozoa in a dormant state in the epididymal lumen (16) and has been postulated to be a positive factor for the transfer of proteins from the epithelium to sperm via epididymosomes (53).
THE EPIDIDYMIS IS AN IMPORTANT male reproductive organ involved in the maturation and storage of spermatozoa. The pseudostratified epithelium of the epididymis is composed of numerous cell types, including principal, basal, and clear cells that function in concert to tightly regulate the luminal environment in which sperm transit (51) . One major function of clear cells in the epididymis is to acidify the luminal fluid via the vacuolar proton-pumping H ϩ -ATPase (V-ATPase), which is located on the apical membrane (6, 7, 13, 14) . Under resting conditions, a large fraction of V-ATPase resides in a subapical pool of vesicles, and upon activation the V-ATPase is trafficked to the apical membrane. This is accompanied by an increase in apical membrane surface area resulting in the formation and elongation of apical microvillar projections. Thus microvilli elongation directly correlates with V-ATPase activity and has been used as a measure of clear cell activation (6, 7, 19, 39, 49) . The importance of clear cells to male fertility has been demonstrated, as impairment of V-ATPase activity by genetic manipulation or by environmental factors causes male infertility (11, 27, 61) . An acidic pH is important for maintaining spermatozoa in a dormant state in the epididymal lumen (16) and has been postulated to be a positive factor for the transfer of proteins from the epithelium to sperm via epididymosomes (53) .
In recent years, the physiological regulation of clear cell proton pumping activity in the epididymis has begun to be elucidated. We have previously shown that clear cells are regulated via both nonhormonal and hormonal factors. For example, clear cells can be directly activated by nonhormonal luminal factors, such as bicarbonate, H ϩ , ATP, and adenosine (7, 39) . Clear cells are also indirectly activated by hormones, such as angiotensin II (ANG II) in the lumen, via cell-cell cross talk with adjacent basal cells (50) . Altogether, these results demonstrate that clear cells actively sense and respond to their local environment to maintain an acidic luminal pH necessary for sperm maturation and storage. In contrast, there have been few reports to date demonstrating the regulation of clear cell activity in the epididymis via systemic mechanisms involving either nonhormonal or hormonal factors. It is known, however, that the postnatal appearance and survival of clear cells in the epididymis are dependent on systemic levels of sex hormones, but it is unclear whether this effect is direct or indirect (23) .
As discussed above, ANG II indirectly regulates clear cell activity in the epididymis (50) . ANG II is one of many effectors of the renin-angiotensin-system (RAAS), which also includes renin, angiotensin I (ANG I), and aldosterone. The RAAS is best known as an important hormone system for the control of body fluid volume and electrolyte balance by the kidney (48) . In response to a decrease in renal perfusion pressure, juxtaglomerular cells release renin into the circulation, which participates in the conversion of angiotensinogen (released by the liver) into ANG I. ANG I is then converted into ANG II by the angiotensin-converting enzyme (ACE). ANG II and its metabolites then act on cells in the renal distal tubule and collecting duct to regulate fluid reabsorption and electrolyte balance. In addition, ANG II can activate the synthesis of the mineralo-corticoid hormone aldosterone in the zona glomerulosa of the adrenal cortex, which, in concert with ANG II, acts on aldosterone-sensitive cells of the distal tubule and collecting duct to further increase fluid reabsorption and regulate compensatory electrolyte balance (52) . Traditionally the cellular responses to aldosterone have been associated with genomic effects. However, recent studies have also shown a direct nongenomic regulation of intercalated cell function in the kidney by aldosterone (63, 64) . Intercalated cells are similar to epididymal clear cells; they can also express high levels of V-ATPase in their plasma membrane and are involved in luminal acidification in the kidney. This acidification process is stimulated by aldosterone via the recruitment of V-ATPase to the plasma membrane (52, 56, 64) .
Interestingly, the RAAS is also involved in the local control of fluid and electrolyte balance in other organ systems (41) . In the male reproductive system, the same (angiotensinogen, ANG I, ANG II, and aldosterone) or similar players (bradykinin and testicular ACE) in the RAAS exist to regulate fluid and electrolyte balance (8, 34, 47) . In particular, aldosterone plays an important role in the maintenance of fluid absorption and electrolyte balance in the epididymis. Adrenalectomy or spironolactone treatment caused a decrease in Na ϩ reabsorption, which was followed by a decrease in water absorption resulting in a decrease in sperm concentration in the epididymis. The effect of adrenalectomy was partially reversed with aldosterone replacement (3, 29, 58, 65) . Importantly, the effect of spironolactone was not affected by simultaneous treatment with testosterone, demonstrating the specificity of spironolactone as a mineralocorticoid receptor (MR) antagonist in these experiments (58) .
Aldosterone is a steroid hormone that specifically binds to the MR, which is encoded by the nuclear receptor subfamily 3, group C member 2, (NR3C2) gene, and causes both rapid nongenomic and slow genomic effects on cell activity (22, 24, 26, 32, 56) . Rapid nongenomic effects of aldosterone have been reported in several organs (22, 24, 56) . It has been suggested that the nongenomic effects of aldosterone occur via membrane-bound receptors, utilizing numerous signaling pathways, including the PKA and PKC signaling pathways (56) . Other circulating steroid hormones, such as cortisol, can also activate MR. Therefore, the cytoplasmic level of active cortisol must be lowered in order for aldosterone to activate MR. In aldosterone-sensitive cells, MR is therefore coexpressed with the 11␤-hydroxysteroid dehydrogenase type 2 enzyme (HSD11␤2), which acts to lower active cortisol levels in the cytoplasm. The serum concentration of aldosterone in rodents has been measured to range from 0.5 Ϯ 0.08 to 1.6 Ϯ 0.2 nM (38, 55) .
In the epididymis, aldosterone binds to a high-affinity (K d : ϳ1 nM) type I (MR) receptor, which is highly enriched in a single population of epithelial cells, the clear cells (28, 44) . In addition, HSD11␤2 gene expression has been detected in the epididymis and is also enriched in clear cells (37, 62) . A recent publication showed immunolocalization of MR and HSD11␤2 in clear cells of the adult rat caput but not the cauda (25) . Therefore, clear cells appear to have all the tools necessary to respond to aldosterone. We, thus, hypothesized that circulating aldosterone may play a role in luminal acidification of the epididymis via the V-ATPase expressed in clear cells.
In this study we, therefore, sought to determine the effect of acute aldosterone treatment on clear cell activity in the epididymis in vivo. We first confirmed the coexpression of NR3C2 and HSD11␤2 in clear cells of the epididymis and then measured the regional-specific activation of clear cells following a tail vein injection of aldosterone in mice. The direct stimulation of epididymal clear cell activity by aldosterone was also examined using isolated clear cells from B1-enhanced green fluorescent protein (EGFP) transgenic mice, in which expression of EGFP is driven by the promoter for the B1-subunit isoform of the V-ATPase (35) .
MATERIALS AND METHODS
Animals. Male Sprague-Dawley rats (85 days old) were obtained from Charles River Laboratories (Wilmington, MA). The generation and characterization of transgenic mice that express EGFP under the control of the ATP6V1B1 gene promoter have been previously described (35) , and these are further referred to as B1-EGFP transgenic mice. All animals were housed and used in compliance with the Institutional Animal Care and Use Committees of the Massachusetts General Hospital (MGH). Animals had access to water and were kept on a standard food diet ad libitum. Nembutal (pentobarbital; 60 mg/kg wt ip) was used to anesthetize animals before drug infusion or cell isolation.
Isolation of clear cells from B1-EGFP transgenic mice. Isolation of EGFP-positive clear cells from B1-EGFP mice was performed as previously described (18) . EGFP-negative cells, which correspond to all other cell types in the epididymis, were also collected. Briefly, the epididymides were dissected, minced, and incubated in isolation buffer containing 1 mg/ml collagenase I, 1 mg/ml collagenase II (Invitrogen, Carlsbad, CA), and 10 mM HEPES (pH 7.5) in RPMI 1640 medium (Invitrogen) at 37°C with gentle shaking (1,000 rpm) every 1 min (for 10 s each time) for a duration of 35 min. Twentyseven-day-old mice were used to avoid contamination with spermatozoa in the cell suspension. Isolated cells were passed through a 70-m filter; washed once in complete Iscove's modified Dulbecco's medium containing 10% fetal bovine serum, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 4 mM L-glutamine, 50 U/ml penicillin, 50 g/ml streptomycin (all from Invitrogen), and 1 nM 5␣-dihydrotestosterone (Sigma-Aldrich, St. Louis, MO); and centrifuged at 200 g for 10 min. The isolated cells were either suspended in complete Iscove's modified Dulbecco's medium and plated onto 35-mm glass bottom dishes (Mattek, Ashland, MA) to be used for live cell imaging, or subjected to fluorescence-activated cell sorting (FACS). Cells for FACS were further passed through a 35-m filter, and isolation of a clear cell population by FACS was performed at the MGH Flow Cytometry Core facility (Boston, MA). The validity and assessment of contamination of our FACS isolation technique have been shown previously (18, 46, 59) .
Total RNA extraction and RT-PCR. EGFP-positive clear cells and EGFP-negative cells were isolated by FACS, either from the entire epididymis of 3 B1-EGFP mice or separately from the caput and cauda epididymis of four mice (46) . Total RNA was extracted using RNeasy micro kit (Qiagen, Valencia, CA) following the manufacturer's protocol. RNase-Free DNase set (Qiagen) was then used to remove contaminating genomic DNA, and extracted RNA was stored at Ϫ80°C until use. RNA was reverse transcribed using 1ϫ PCR buffer II, 1 mM deoxynucleotide triphosphate (dNTP) mix, 1.25 M random hexamers, 1.25 M oligo d(T), 5 mM MgCl 2, 1 U/l RNaseOUT recombinant ribonuclease inhibitor, and 2.5 U/l MuLV reverse transcriptase enzyme (all from Invitrogen) in a final volume of 50 l. Reverse transcription was performed at 42°C for 1 h and cDNA was stored at Ϫ20°C until use. Primers (Invitrogen) were designed to amplify a region spanning exons and tested to confirm the absence of genomic DNA amplification by performing a negative RT reaction, omitting the MuLV reverse transcriptase enzyme. Primers used for PCR were as follows: NR3C2 (153 bp): forward 5=-ATGGAAAC-CACACGGTGACCT-3= and reverse 5=-AGCCTCATCTCCACA-CACCAAG-3=; and HSD11␤2 (143 bp): forward 5=-ACCCCTGCT-TGGCAGCCTACGGCA-3= and reverse 5=-TCACATTAGTCACT-GCCTCTGTCTTG-3=. Sequences for GAPDH were previously published by our group and were used as controls (20) . PCR amplification was performed in a total volume of 20 l containing 2 l cDNA, 500 pM of each primer, 1ϫ PCR buffer II, 1.25 mM MgCl 2, 200 M dNTP mix, and 1.25 U of hot-start Taq DNA polymerase (Invitrogen). Following an initial denaturation at 95°C for 8 min to activate the DNA polymerase, samples were denatured at 95°C for 30 s, allowed to anneal at 60°C for 30 s, and extended at 72°C for 45 s for 35 cycles. The samples were allowed a final extension at 72°C for 10 min. The PCR products (12.5 l) were visualized by gel electrophoresis using 2.5% agarose gels containing GelStar stain (Lonza Bioscience, Basel, Switzerland).
Drug treatments and tissue collection. A tail vein cannulation was set up for drug infusion experiments using a 30-gauge needle and PE10 tubing. The PE10 tubing was then connected to an injection site (World Precision Instruments, Sarasota, FL) for infusion directly into the circulatory system. A 200-l bolus of either PBS, aldosterone (200 nM, Sigma-Aldrich), 8-(4-chlorophenylthio)adenosine 3=,5=-cylic monophosphate (cpt-cAMP; 20 mM, Sigma-Aldrich), or 1,2-dioctanoyl-sn-glycerol (DOG; 20 M, Sigma-Aldrich) was first injected and was then followed by an infusion of 600 l of either PBS or drug over 15 min using an infusion pump (KdScientific, Holliston, MA) at a rate of 2.4 ml/h. The doses used here are based on previously published studies showing activation of V-ATPase-proton secretion in renal intercalated cells by these agonists in vivo (43, 63, 64) . The final aldosterone concentration injected into the animals was estimated to be ϳ1.55 nM, based on an average extracellular fluid volume of 103 ml for an adult rat (21, 33, 36, 60) . This dose corresponds to the values reached under conditions of dietary sodium restriction or hyperkalemia in humans (45) . Tissues were fixed by left ventricular perfusion of PBS followed by fixative containing 4% vol/vol paraformaldehyde, 75 mM lysine, 10 mM sodium periodate, and 5% wt/vol sucrose in 100 mM sodium phosphate buffer (PLP). Epididymides were collected and further fixed by immersion in PLP overnight at 4°C. Tissues were then washed 3ϫ with PBS and stored in PBS containing 0.02% Na azide. Tissues were cryoprotected with 30% sucrose overnight at 4°C and then embedded in Tissue-Tek optimum cutting temperature compound (Sakura Finetek, Torrance, CA), mounted, and frozen at Ϫ20°C. Cryosections were cut using a Leica CM3050-S microtome (Leica Microsystems, Buffalo, IL). Sections of 10-to 16-m thickness were collected onto Fisherbrand Superfrost Plus microscope slides (Fisher Scientific, Pittsburg, PA).
Immunofluorescence and antibodies. Double-immunofluorescence labeling was performed on cryosections as previously described (6, 50) . Briefly, cryosections were hydrated in PBS for 15 min and incubated with 1% v/v SDS for 4 min (15). Cryosections were then washed 3 times with PBS and blocked with 1% bovine serum albumin in PBS for 15 min. Primary antibodies used were affinity purified rabbit polyclonal IgG raised against the 56-kDa B1 subunit of V-ATPase (42) and affinity purified mouse monoclonal antibody raised against the heavy chain of clathrin (180 kDa; BD Biosciences, San Jose, CA), diluted in DAKO medium (DAKO, Carpinteria, CA). Donkey FITCconjugated anti-rabbit and donkey Cy3-conjugated anti-mouse secondary antibodies were used following the manufacturer's protocol (Jackson Immunoresearch Laboratories, West Grove, PA). Slides were mounted with Vectashield mounting medium (Vecta Laboratories, Burlingame, CA), and images were taken on a Zeiss Radiance 2000 confocal microscope.
Quantification of microvillar domain length. Volocity software (v. 5.0; Perkin Elmer, Waltham, MA) was used to quantify microvilli surface area, which was measured as a surrogate marker for the accumulation of V-ATPase in the apical membrane of clear cells. The apical region of clear cells was defined by the presence of clathrin, and the microvillar domain area was defined as the area of V-ATPase labeling detected above the apical pole, as we have previously described (50) . The length of the microvillar domain was calculated by dividing the area occupied by microvilli by the width of the apical pole. Images were taken only of clear cells showing a clear longitudinal section from the apical to the basal poles of the cell. The length of the microvillar domain was determined from 5 clear cells per epididymis from 4 animals for a total of 20 cells per treatment.
Intracellular pH measurements. Isolated epididymal cells plated on glass-bottomed dishes were transferred to a thermostatically controlled stage equipped with a perfusion system (perfusion rate ϳ1.2 ml/min, volume ϳ300 l) maintained at 32°C on a Nikon A1 resonant scanning confocal inverted microscope (Nikon Instruments, Melville, NY) equipped with a ϫ60 oil immersion objective (NA ϭ 1.45 and WD ϭ 0.13 mm) and a Nikon Perfect Focus System. Only EGFPpositive cells were visualized and selected for intracellular pH measurements. Medium was exchanged with control solution (in mM: 125 NaCl, 5 KCl, 5 NMDG-Cl, 1.8 CaCl 2, 1.2 MgCl2, 4 NaH2PO4, and 5 HEPES) containing the pH indicator, 5 M seminaphthorhodafluor-5F-5-(and 6)-carboxylic acid, acetoxymethyl ester acetate (SNARF-5F-AM; Invitrogen), and either vehicle or the indicated drug treatment. Cells were incubated in SNARF-5F-AM, which is membrane permeant and is esterified in the cytoplasm within seconds to become membrane impermeant, and the indicated drug for 20 min. Cells were then washed in control solution for 5 min to remove residual nonesterified SNARF-5F-AM in the solution before time-lapse imaging. Additional drugs used for intracellular pH (pH i) measurements were the V-ATPase inhibitor concanamycin A (Con A; Wako Chemicals, Richmond, VA), the MR antagonist spironolactone (Spiro, SigmaAldrich), the glucocorticoid receptor antagonist mifepristone (Mife, Sigma-Aldrich), the PKC inhibitor, chelerythrine (Chel; Sigma-Aldrich), and the PKA inhibitor myristoylated-protein kinase inhibitor (mPKI; Sigma-Aldrich). Inhibitors were added 15 min before and were present throughout the intracellular pH measurements. SNARF-5F was excited with a 514-nm laser and the emission was detected using a multi-anode photomultiplier tube spectral detector set up to collect the emitted light between 510-to 530 (520)-, 570-to 590 (580)-, and 630-to 650 (640)-nm wavelengths simultaneously. In this set up, no light was detected above background in the 520-nm channel, ruling out the possibility that light from EGFP would bleed through into either the 580-or 640-nm channel. Cells were perfused with control solution for 5 min and then in the absence of sodium (Na-free solution containing in mM: 1 KCl, 134 NMDG-Cl, 1.8 CaCl2, 1.2 MgCl2, 4 KH2PO4, and 5 HEPES) for 5 min. An ammonium pulse was then applied in the absence of sodium (in mM: 1 KCl, 94 NMDG-Cl, 20 NH4Cl, 1.8 CaCl, 1.2 MgCl, 4 KH2PO4, and 5 HEPES) for 5 min, followed by the Na-free solution for 10 min and finally control solution again for 5 min. Solution osmolarity was measured in a vapor pressure osmometer (Wescor, Logan, UT), and the final osmolarity was adjusted to 300 mosM with raffinose, an effective osmolyte in the epididymis (8) . Images were taken every 20 s and imported into Volocity software. The pixel intensity was recorded from an intracellular area ϳ2 m 2 (ϳ100 total pixels), and care was taken to avoid the nucleus and large intracellular vesicles. The 580-to 640-nm ratios were converted to pH using a calibration curve obtained by incubating cells with nigericin (10 M) in the presence of a solution containing high-K ϩ at different pH values. The rate of intracellular alkalization was measured during the initial 5-min window following the NH4Cl pulse. The first pHi value for this 5-min window was chosen to be the lowest value within the first 1 min (3 data points) after the rapid drop in pHi. The data were fit to a linear curve using Prism software (v. 4.0; GraphPad Software, La Jolla, CA), and the best-fit linear curve was overlaid onto the pHi trace (dotted red line). The rate of pHi recovery was determined from the average of 2-4 cells per region per animal from 3-12 animals.
Statistical analysis. For microvilli length measurements, data were analyzed using Student's t-test for unpaired values. For intracellular pH measurements, the data were first analyzed using Student's t-test for unpaired values then analyzed using one-way ANOVA followed by a Tukey's post hoc test where indicated. A value of P Ͻ 0.05 was considered significant. Data were expressed as the means Ϯ SE where indicated. (25, 28, 37, 44, 62) . We, therefore, set out to confirm these results at the mRNA level, using our EGFP transgenic mice, in which the expression of EGFP is under the control of a clear cell specific promoter (35) (Fig. 1A) (Fig. 1B) . A very low NR3C2 mRNA expression was detected in both EGFP ϩ and EGFP Ϫ cells in the cauda. Therefore, our results confirm the enriched mRNA expression of both NR3C2 and HSD11␤2 genes to clear cells in the caput region of the epididymis, suggesting that these cells may be poised to respond to circulating aldosterone.
RESULTS

Detection of NR3C2 and
Aldosterone induces clear cell activation in the caput rat epididymis. To test whether clear cells in the epididymis are sensitive to circulating levels of mineralocorticoids, we injected aldosterone (200 nM) into rats via a tail vein infusion and measured clear cell activation using confocal microscopy in different regions of the epididymis (Fig. 2) . As shown in Fig.  2A , under control conditions clear cells of the caput region have very few short V-ATPase-labeled microvilli emanating from the apical membrane. Infusion of aldosterone over 15 min caused an increase in the number and length of microvilli projections (Fig. 2B) . To quantify the level of clear cell activation, the average length of the microvillar domain was determined as described in MATERIALS AND METHODS. Figure 2 , A' and B', depicts how the microvillar domain was determined under control and aldosterone conditions, respectively. In control animals the average length of the microvillar domain was 0.91 Ϯ 0.10 m and was increased to 1.35 Ϯ 0.12 m by aldosterone ( Fig. 2C ; P Ͻ 0.05; n ϭ 4), representing an increase of 48%. In the cauda epididymis, under control conditions clear cells also have very few short microvilli (Fig. 2D) , similar to clear cells in the caput (Fig. 2A) . In contrast to the caput region, however, aldosterone treatment did not induce a statistically significant activation of clear cells in the cauda (Fig. 2E) . The average length of the microvillar domain in the cauda was 0.94 Ϯ 0.27 m in control animals and 1.02 Ϯ 0.26 m after aldosterone treatment ( Fig. 2F ; P ϭ 0.84; n ϭ 4). Aldosterone also did not activate clear cells in other regions of the epididymis, including initial segment, corpus, and initial vas deferens (data not shown). These results suggest that the activation of clear cells by circulating aldosterone is region specific and occurs in the caput region in the epididymis. Our results also demonstrate that aldosterone has a rapid effect on clear cell activity. This suggests the possible involvement of nongenomic signaling pathways, such as those involving PKA and PKC, leading to clear cell activation.
To test the involvement of PKA and PKC signaling pathways in the activation of clear cells by aldosterone in vivo, we next infused the membrane permeant cAMP analog cpt-cAMP (20 mM) or the PKC activator DOG (20 M), via tail vein injection, and measured the average length of the clear cell microvillar domain, as described for aldosterone treatment. As shown in Fig. 3 , cpt-cAMP induced a significant increase in the microvillar domain length in clear cells from the caput region (Fig. 3, A and B) , while no effect was detected in clear cells from the cauda (Fig. 3, D and E) . The average length of the microvillar domain in control clear cells in the caput was 0.81 Ϯ 0.07 m and was increased to 1.11 Ϯ 0.01 m (a 37% increase) after cpt-cAMP treatment ( Fig. 3C ; P Ͻ 0.05; n ϭ 4). Similar to the findings with aldosterone, cpt-cAMP did not significantly activate clear cells in the cauda. The average length of the microvillar domain in control clear cells in the cauda was 0.51 Ϯ 0.02 and 0.66 Ϯ 0.07 m after cpt-cAMP (20 mM) treatment ( Fig. 3F ; P ϭ 0.09; n ϭ 4). Finally, DOG also induced an increase in the microvilli length only in clear cells from the caput (Fig. 4, A and B) but not in clear cells from the cauda (Fig. 4, D and E) . The average length of the microvillar domain in control clear cells in the caput was 0.61 Ϯ 0.05 m and was increased to 1.14 Ϯ 0.05 m after DOG treatment ( Fig. 4C ; P Ͻ 0.05; n ϭ 4). The average length of the microvillar domain in control clear cells in the cauda was 0.51 Ϯ 0.06 m and was 0.69 Ϯ 0.08 m after DOG treatment ( Fig. 4F ; P ϭ 0.13; n ϭ 4). Thus our results show that, similarly to aldosterone, cpt-cAMP and DOG infused into the circulation activate clear cells in the caput but not the cauda region.
Aldosterone increases V-ATPase activity in clear cells isolated from the caput epididymis but not from the cauda.
V-ATPase proton pumping activity was determined in isolated EGFP-expressing clear cells by measuring the rate of Na ϩ -and bicarbonate-independent intracellular alkalization following an acid load induced by the NH 4 Cl pulse method (Fig. 5) . pH i was measured using the pH-sensitive dye SNARF-5F, and an example of single cell images acquired is shown in Fig. 5A . In control clear cells isolated from the caput, the initial pH i was 7.52 Ϯ 0.05 (n ϭ 10). In some cells pH i decreased slightly when the solution was exchanged to 0 Na ϩ and in all cells it increased when the solution was exchanged for 0 Na ϩ /NH 4 Cl (Fig. 5B, left) . Immediately after the solution was exchanged back to 0 Na ϩ , pH i acidified to 6.46 Ϯ 0.09 and remained low, showing no Na ϩ -and bicarbonate-independent pH i recovery (Fig. 5B, red line at left) . Upon reintroduction of sodium into the solution pH i rapidly increased toward initial pH i values. This is presumably due to the intrinsic activity of Na ϩ /H ϩ exchangers (NHE), most notably the ubiquitously expressed NHE1 isoform, which is located in the basolateral membrane of clear cells (17) . To test for a rapid effect of aldosterone, caput clear cells were preincubated for 20 min in aldosterone (20 nM) in control solution before application of the ammonium pulse. In contrast to controls, a Na ϩ -and bicarbonateindependent pH i recovery was observed (Fig. 5B : red line at right) after aldosterone stimulation. As shown in Fig. 5C , the rate of pH i recovery following an ammonium pulse was Ϫ0.01 Ϯ 0.01 pH units/min under control conditions (Control; n ϭ 10) and was increased to ϩ0.04 Ϯ 0.01 pH units/min after aldosterone stimulation (Aldo; P Ͻ 0.05 vs. Control; n ϭ 12). The increase in intracellular alkalization caused by aldosterone was inhibited by the V-ATPase inhibitor concanamycin A, such that the rate of intracellular alkalization was reduced to ϩ0.006 Ϯ 0.004 pH units/min (Fig. 5C , Aldo ϩ ConA; P Ͻ 0.05 vs. Aldo; n ϭ 3), confirming the major involvement of V-ATPase in pH i recovery. The MR antagonist spironolactone (10 M) inhibited the aldosterone-stimulated increase, such that the rate was reduced to Ϫ0.01 Ϯ 0.01 pH units/min (Fig.  5C , Aldo ϩ Spiro; P Ͻ 0.05 vs. Aldo; n ϭ 3). In contrast, the glucocorticoid receptor antagonist mifepristone (1 M) had no statistically significant effect on aldosterone-stimulated pH i recovery and the rate was ϩ0.02 Ϯ 0.01 pH units/min (Fig. 5C , Aldo ϩ Mife; P Ͻ 0.05 vs. Control, n ϭ 3). The PKC inhibitor chelerythrine (1 M) inhibited the aldosterone-stimulated increase in V-ATPase activity, such that the rate of pH i recovery after an acid load was Ϫ0.02 Ϯ 0.01 pH units/min (Fig. 5C , Aldo ϩ Chel; P Ͻ 0.05 vs. Aldo; n ϭ 5). In contrast, the PKA inhibitor mPKI (5 M) had no statistically significant effect on the stimulation induced by aldosterone, and the pH i recovery was ϩ0.06 Ϯ 0.04 pH units/min (Fig. 5C , Aldo ϩ mPKI; P Ͻ 0.05 vs. Control; n ϭ 3). Finally, cpt-cAMP (3 M) and DOG (1 M) both increased the rate of pH i recovery to ϩ0.03 Ϯ 0.01 pH units/min ( Fig. 5C ; P Ͻ 0.05 vs. Control; n ϭ 3) and ϩ0.02 Ϯ 0.0001 pH units/min ( Fig. 5C ; P Ͻ 0.05 vs. Control; n ϭ 3), respectively. These results demonstrate that the aldosterone-dependent increase in V-ATPase activity is sensitive to inhibitors of PKC, but not PKA, although stimulation of both the PKC and PKA pathways can increase V-ATPase activity in caput clear cells.
In control clear cells isolated from the cauda, the initial pH i was 7.45 Ϯ 0.1 (n ϭ 8). In some cells pH i decreased slightly when the solution was exchanged to 0 Na ϩ and in all cells it increased when the solution was exchanged for 0 Na ϩ /NH 4 Cl. Immediately after the solution was exchanged back to 0 Na ϩ , pH i acidified to 6.39 Ϯ 0.15 (not statistically significant compared with caput clear cells). In contrast to caput clear cells, a higher rate of Na ϩ -and bicarbonate-independent pH i recovery was observed (ϩ0.05 Ϯ 0.02 pH units/min) even under control conditions (without aldosterone stimulation; Fig. 5D , red line at left; P Ͻ 0.05, vs. Control caput cells; n ϭ 8), suggesting a higher basal V-ATPase proton pumping activity in freshly isolated cauda clear cells. This might be due to the larger apical surface area of "resting" cauda clear cells compared with caput clear cells, which have a narrower apical width (e.g., compare cells shown in Fig. 4, A and D) . Upon reintroduction of Na ϩ , pH i rapidly increased toward initial control pH i values. Aldosterone did not further stimulate V-ATPase activity in these cells (Fig. 5D , red line at right) and the rate of pH i recovery after an NH 4 Cl-induced acid load was ϩ0.04 Ϯ 0.01 pH units/min ( Fig. 5E ; P ϭ 0.48 vs. Control; n ϭ 8). Concanamycin A inhibited completely the high basal rate of pH i recovery, such that the rate was Ϫ0.01 Ϯ 0.01 pH units/min ( Fig. 5E ; P Ͻ 0.05 vs. Control; n ϭ 3), confirming the major involvement of the V-ATPase in this process. Furthermore, none of the treatments had any statistically significant effect on the initial pH i or the acidification induced by the NH 4 Cl pulse in either caput or cauda cells (data not shown).
DISCUSSION
In this study we show that NR3C2 and HSD11␤2 mRNA expression is highly enriched in clear cells isolated from the caput epididymis and demonstrate that tail vein injection of aldosterone, cpt-cAMP, and DOG stimulates microvilli extension in these cells in the caput but not the cauda region in vivo. In addition, the effect of aldosterone on clear cell activity appears to be rapid and direct, as clear cells isolated from the caput region of the epididymis also respond to aldosterone in vitro by increasing proton pumping activity of the V-ATPase, quantified using a fluorescence-based intracellular acidification assay.
Implications of restricted NR3C2 and HSD11␤2 expression in clear cells. The RAAS has been implicated in the control of numerous biological systems, such as blood volume, and more recently in the local control of several organ systems (41) . Previous research has shown the specific binding of [ (25, 28, 37, 44, 62) . Our results further demonstrate the enriched mRNA expression of NR3C2 and HSD11␤2 in clear cells isolated by FACS from the caput mouse epididymis, and the absence of HSD11␤2 mRNA in cauda clear cells. This is in contrast to the collecting duct of the kidney where MR and HSD11␤2 are present in both intercalated and principal cells (2, 56) . In the present study, the rapid (minutes) time course of V-ATPase activation and elongation of V-ATPase-rich mi- crovilli in clear cells indicates a nongenomic effect of aldosterone, although no direct evidence is provided here to support this statement. There is still debate as to whether the classical aldosterone receptor (MR) and HSD11␤2 are sufficient to initiate such nongenomic effects, in addition to the classic genomic effects, of aldosterone (22, 24, 56) . If we assume that they are, then this would suggest that in the epididymis, direct effects of aldosterone would be restricted to clear cells. However, previous studies have shown long-term modulation of electrolyte and fluid transport in epididymal principal cells by aldosterone (3, 29, 58, 65) , indicating potential NR3C2-and HSD11␤2-independent signaling. Recent studies have indicated the existence of other aldosterone receptors in addition to the classic NR3C2 (32, 56) , and it remains possible that the response of epididymal principal cells to aldosterone could be attributed to these still incompletely characterized receptors. Not surprisingly, all NR3C2
Ϫ/Ϫ and most HSD11␤2 Ϫ/Ϫ mice die at an early age. However, the fertility of surviving adult HSD11␤2 Ϫ/Ϫ mice appears normal (9, 10, 31) . In HSD11␤2 Ϫ/Ϫ animals, it is conceivable that cortisol occupies all MRs. This could activate clear cells even without aldosterone stimulation, thus promoting "constitutive" luminal acidification by these cells in these mice. Alternatively, other aldosterone receptors might provide compensatory mechanisms in the absence of MR in NR3C2 Ϫ/Ϫ mice. In addition, data regarding male infertility in human patients with abnormal aldosterone signaling, such as pseudohypoaldosteronism type I and II, are lacking, and the relative importance of aldosterone to male fertility remains to be determined.
Circulating aldosterone activates proton-secreting clear cells in the caput epididymis but not the cauda. Our results demonstrate that an acute systemic administration of aldosterone, as well as the permeant cAMP analog (cpt-cAMP) or PKC activator (DOG), stimulate the formation and elongation of V-ATPase-labeled microvilli in clear cells from the caput but not the cauda region of the epididymis. These results indicate an amplification of the amount of V-ATPase present at the cell surface via either activation of the exocytosis of V-ATPase-rich vesicles or via inhibition of endocytosis. As a positive control we also analyzed sections from the kidney of mice treated with aldosterone, cpt-cAMP, or DOG and observed increased V-ATPase-rich microvilli projections in intercalated cells (data not shown), similar to our recently published observations (43, 63) . In addition to being regulated via recycling mechanisms, previous studies conducted mainly in yeast and insects have shown that V-ATPase activity can also be regulated via local assembly/disassembly of V-ATPase subunits (12, 30, 57) . Future studies will be required to determine whether or not the rapid effect of aldosterone described here can also be the result of local assembly of preexisting V-ATPase subunits in addition to recycling modulation.
Previous studies have shown that systemic metabolic alkalosis and acidosis decreased and increased luminal acidification in the epididymis, respectively (4). Metabolic acidosis stimulates a cascade of biological effects, including the increased production of aldosterone from the adrenal gland (5) . The increased epididymal luminal acidification observed during systemic metabolic acidosis (4) might be attributed to a genomic effect by aldosterone, in addition to the acute effect of aldosterone described here. Since epididymal caput clear cells express NR3C2, it is also possible that aldosterone stimulates the long-term regulation of clear cell activity (e.g., by increased expression of V-ATPase subunits). Numerous reports have demonstrated the regulation of epididymal function by the RAAS. Our results extend this pathway to now include aldosterone in the regulation of luminal acidification via clear cells in the epididymis. In addition, we also describe here the first direct systemic hormonal regulation of clear cells in the epididymis to date.
Why did aldosterone, cpt-cAMP, and DOG increase microvilli elongation in clear cells in the caput and not the cauda in vivo? A complex network of blood vessels irrigates the epididymis (54) . The initial segment and caput region is supplied from the testicular artery, whereas the cauda region is supplied from the deferential artery (1, 54). Vascular injection of India ink showed that the head region (which contains the caput), especially the initial segment, is immediately labeled with this dye, suggesting that this region is highly vascularized and might be the first region to respond to circulating agonists. This notion is supported by the fact that cpt-cAMP and DOG activate caput clear cells in vivo but do not lead to a statistically significant effect in the cauda, while we have previously shown a stimulatory effect of cpt-cAMP administered luminally in the perfused rat cauda (40) . In addition, our RT-PCR results demonstrate undetectable mRNA expression of HSD11␤2 in cauda EGFP ϩ clear cells, suggesting that these cells are not able to reduce glucocorticoid levels, a process that is necessary for specific aldosterone action. Altogether, our results indicate that the caput region is more poised to respond to circulating factors, such as aldosterone, than the cauda region. PKC-dependent effect of aldosterone on clear cell activity. Both our in vivo and in vitro data demonstrate that effectors of the PKA (cpt-cAMP) and PKC (DOG) pathways mimic the effect of aldosterone on caput clear cell activity. These results are in agreement with our previous studies showing activation of V-ATPase-dependent proton secretion in renal intercalated cells by these agonists (63) . Previous results from our group have also shown that luminal delivery of drugs that stimulate either the PKA or PKC pathways increase clear cell activity (6, 40) . In the kidney it was suggested that the PKC pathway contributes more than the PKA pathway to the nongenomic effect of aldosterone on intercalated cell V-ATPase activity (63) . In the epididymis we show here that the effect of aldosterone is PKC but not PKA dependent because chelerythrine, but not mPKI inhibited the stimulatory effect of aldosterone on V-ATPase activity. Our results, therefore, are in agreement with the literature suggesting that the signaling cascade-dependent effect of aldosterone is cell type specific. Since chelerythrine is a pan PKC inhibitor, it remains to be determined which PKC isoform is involved in transducing the effect of aldosterone in caput clear cells.
In summary, this study shows that circulating aldosterone triggers the formation and elongation of V-ATPase-rich apical microvilli and stimulates the V-ATPase proton pumping activity in clear cells from the caput, but not in clear cells from the cauda epididymis. The absence of aldosterone stimulation in cauda clear cells correlates with the absence of HSD11␤2 mRNA expression in these cells. Thus our study demonstrates the participation of circulating aldosterone in the regulation of proton secretion in clear cells and identifies the RAAS as an important modulator of luminal acidification in the proximal region of the epididymis. 
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